Alzheimer Disease Clinical Trials
Alzheimer Disease clinical trials study new therapies, devices, and diagnostic tools for alzheimer Disease and related neurological symptoms. Corterve gathers actively recruiting Alzheimer Disease studies from ClinicalTrials.gov so you can filter them by where you live and whether you may qualify. Neurology trials often include cognitive, imaging, or biomarker assessments. This page is informational only and is not medical advice; discuss participation with your neurologist or physician.
Recruiting Alzheimer Disease studies
- Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's DiseaseNCT06847321PHASE2Lighthouse Pharmaceuticals, Inc.Alzheimer DiseasePhoenix, Arizona
- Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's DiseaseNCT06808984PHASE2CelgeneAgitationHomewood, Alabama
- A Master Protocol Studying Multiple Amyloid-Targeting Therapies in Healthy Participants and Participants With Alzheimer's DiseaseNCT07787169PHASE1Eli Lilly and CompanyAlzheimer DiseaseAnaheim, California
- Ultrasonic Debris Clearance to Promote Brain ResilienceNCT07573982NAStanford UniversityAlzheimer s DiseaseStanford, California
- Clinical Study of SNK01 in Participants With Moderate Alzheimer's DiseaseNCT06189963PHASE1, PHASE2NKGen Biotech, Inc.Moderate Alzheimer DiseaseGlendale, California
- DUVAX: A Phase 1 Alzheimer's Vaccine Study Targeting Amyloid-Beta and TauNCT07142278PHASE1Nuravax, Inc.Alzheimer DiseaseMiami Lakes, Florida
- The Gut - PRO StudyNCT07413744PHASE1University of Wisconsin, MadisonAlzheimer DiseaseMadison, Wisconsin
- A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's DiseaseNCT06540833PHASE2Intra-Cellular Therapies, Inc.Psychotic DisordersAnaheim, California
- A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)NCT06937229PHASE3Bristol-Myers SquibbAlzheimer DiseaseChandler, Arizona
- A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)NCT07633470PHASE4Alpha Cognition, IncAlzheimer DiseaseIrvine, California
- A Study of LY3439539 in Participants With Alzheimer's DiseaseNCT07598370PHASE1Eli Lilly and CompanyAlzheimer DiseaseIrvine, California
- Improving Memory in Alzheimer's Disease With Noninvasive Brain StimulationNCT06094192NABoston University Charles River CampusAlzheimer DiseaseBoston, Massachusetts
Alzheimer Disease trials by state
Alzheimer Disease trials by metro
Frequently asked questions
- How do I find recruiting Alzheimer Disease clinical trials?
- Browse the actively recruiting Alzheimer Disease studies listed on this page, or take an assessment to see trials you may qualify for based on your profile.
- Are Alzheimer Disease clinical trials free to join?
- Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.
- Who can take part in a Alzheimer Disease clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.